Related Experiment Video
Updated: Aug 14, 2026

11:40
Quantitative Autonomic Testing
Published on: July 19, 2011
Autonomic Dysfunction After Guillain-Barré Syndrome: Evidence from Comprehensive Autonomic Testing
Rafaella Theologou1,2, Theodora Barkoula3,4, Christiana Ioannou2
12nd Department of Neurology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Journal of Clinical Medicine
|August 13, 2026
Summary
Autonomic dysfunction can persist in Guillain-Barré syndrome (GBS) patients long after the acute phase, even without obvious symptoms. Further research is needed to understand the long-term impact of this dysautonomia.
Area of Science:
- Neurology
- Autonomic Neuroscience
Background:
- Guillain-Barré syndrome (GBS) is an immune-mediated peripheral nervous system disorder.
- Autonomic nervous system involvement is recognized during the acute phase of GBS and may extend into recovery.
Purpose of the Study:
- To investigate the function of the autonomic nervous system in patients with a history of Guillain-Barré syndrome.
- To assess the prevalence and characteristics of autonomic dysfunction in GBS survivors.
Main Methods:
- A cross-sectional exploratory study was conducted.
- Autonomic function was assessed using the Ewing battery with Finapres Nova and sudomotor testing.
- Seventeen patients previously hospitalized with GBS were recruited for follow-up assessments.
Main Results:
- 35% of patients (6/17) showed abnormal findings in at least one component of the Ewing battery.
- 18% of patients (3/17) met criteria for definite generalized dysautonomia.
- Autonomic dysfunction, including abnormal heart rate and blood pressure responses, was observed in a significant portion of GBS patients during follow-up.
Conclusions:
- Autonomic dysfunction can be a persistent issue in Guillain-Barré syndrome patients, extending beyond the acute phase.
- Dysautonomia may be present even in GBS patients without overt autonomic symptoms.
- Larger prospective studies are needed to fully characterize the long-term course and clinical significance of autonomic dysfunction in GBS.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

